Teva raises cash to acquire Cephalon

Leading Israeli pharmaceutical company Teva Pharmaceutical Industries Ltd has announced today that it has entered into Syndicated Credit Facilities totalling US$4 billion. This will enable Teva to conclude the acquisition of US biopharma business Cephalon Inc for US$6.8 billion.

The facility is provided by a team cordinated by HSBC Bank plc. Lenders include Barclays Capital, BNP Paribas, Citi, Credit Suisse, Goldman Sachs International, J.P. Morgan and Morgan Stanley, not to mention Israeli banks Bank Hapoalim and Bank Leumi.

Source: “Teva Signs $4 Billion Syndicated Credit Facilities”, Businessnewsnet, 13 June 2011

Leave a Reply